Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Following injury or surgery to a limb, it is often immobilised to allow tissue healing. Short periods of disuse cause loss of muscle size and strength and impaired mechanical properties of tendons, which leads to reduced function. Strategies to combat these deconditioning adaptations include neuromuscular electrical stimulation (NMES), however at present its effectiveness is limited. Recent research suggests that the effects of NMES can be augmented with blood flow restriction (BFR). At present, the effect of combining these two techniques on muscle function during limb immobilisation is unknown. Furthermore, the impact of BFR training during retraining following immobilisation is unknown.
Following injury or surgery to a limb, it is often immobilised to allow tissue healing. Short periods of disuse cause loss of muscle size and strength and impaired mechanical properties of tendons, which leads to reduced function. Strategies to combat these deconditioning adaptations include neuromuscular electrical stimulation (NMES), however at present its effectiveness is limited. Recent research suggests that the effects of NMES can be augmented with blood flow restriction (BFR). At present, the effect of combining these two techniques on muscle function during limb immobilisation is unknown. Furthermore, the impact of BFR training during retraining following immobilisation is unknown.
This study will examine the effectiveness and feasibility of a neuromuscular electrical stimulation and blood flow restriction protocol during a 7 day period of immobilisation. Multiple measures across several physiological systems will be obtained.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Neuromuscular electrical stimulation with blood flow restriction | Experimental | This is the intervention condition |
|
| No intervention | No Intervention | This is the control condition |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Neuromuscular electrical stimulation with blood flow restriction | Other | Neuromuscular electrical stimulation with blood flow restriction |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in maximal isometric strength via Biodex Dynamometer | Strength measure | Through study completion, an average of 1 year |
| Change in maximal isokinetic strength via Biodex Dynamometer | Strength measure | Through study completion, an average of 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Change in muscle endurance via Biodex Dynamometer | Endurance measure | Through study completion, an average of 1 year |
| Change in muscle morphology via 2D and 3D ultrasonography | Morphology measure |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Luke Hughes, PhD | Contact | 0208 240 4058 | 4058 | Luke.hughes@stmarys.ac.uk |
| Stephen Patterson, PhD | Contact | Stephen.patterson@stmarys.ac.uk |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009133 | Muscular Atrophy |
| D020966 | Muscular Disorders, Atrophic |
| ID | Term |
|---|---|
| D020879 | Neuromuscular Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D001284 | Atrophy |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Through study completion, an average of 1 year |
| Change in muscle VO2 via near-infrared spectroscopy | VO2 measure | Through study completion, an average of 1 year |
| Change in blood markers via venous blood samples | Blood markers | Through study completion, an average of 1 year |
| Change in pressure pain thresholds via handheld allometry | Pain measure | Through study completion, an average of 1 year |
| Change in corticomotor excitability and inhibition, via transcranial magnetic stimulation | Corticospinal function | Through study completion, an average of 1 year |
| D020763 |
| Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012816 | Signs and Symptoms |
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D009468 | Neuromuscular Diseases |